ONC212

CAS No. 1807861-48-8

ONC212( —— )

Catalog No. M20724 CAS No. 1807861-48-8

ONC212 a fluorinated-ONC201 analogue is a selective agonist of GPR132.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 92 In Stock
5MG 93 In Stock
10MG 154 In Stock
25MG 261 In Stock
50MG 410 In Stock
100MG 604 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ONC212
  • Note
    Research use only, not for human use.
  • Brief Description
    ONC212 a fluorinated-ONC201 analogue is a selective agonist of GPR132.
  • Description
    ONC212 a fluorinated-ONC201 analogue is a selective agonist of GPR132.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    GHSR
  • Recptor
    GPR132
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1807861-48-8
  • Formula Weight
    440.46
  • Molecular Formula
    C24H23F3N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:50 mg/mL (113.52 mM)
  • SMILES
    FC(F)(F)c1ccc(CN2C3=NCCN3C3=C(CN(Cc4ccccc4)CC3)C2=O)cc1
  • Chemical Name
    246789-Hexahydro-7-(phenylmethyl)-4-[[4-(trifluoromethyl)phenyl]methyl]imidazo[12-a]pyrido[34-e]pyrimidin-5(1H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nii T Prabhu VV Ruvolo Vet al.Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia[J].Leukemia. 2019 Dec;33(12):2805-2816.
molnova catalog
related products
  • Anamorelin hydrochlo...

    A non-peptide, centrally-penetrant and selective agonist of GHSR with appetite-enhancing and anabolic effects.

  • Relamorelin

    Relamorelin(BIM28131, RM131) is a selective and potent ghrelin/growth hormone secretagogue receptor (GHSR) agonist with high affinity for GHS-1a receptor (Ki value is 0.42 ± 0.063 nM).

  • TAPI-1

    TAPI-1, an ADAM17/TACE inhibitor, inhibits shedding of cytokine receptors.